Life science VC Vertex Ventures HC raises $200M in new fund

Vertex Ventures HC is launching its largest fund yet, with $200 million and co-led by former pharma exec Christine Brennan.

Vertex Ventures HC (VVHC) said Tuesday that it launched its third fund, which will be run by Lori Hu, a founding member of VVHC, and Brennan, former chief business officer at Vitae Pharmaceuticals and the former head of strategy and operations of business development at the Novartis Institutes for BioMedical Research.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Roche’s TIGIT win limited by standard of care change, lack of global study

Roche’s TIGIT antibody tiragolumab finally scored a Phase III win following two consecutive late-stage fails last year, thanks to its SKYSCRAPER-08 trial comparing its TIGIT

January 18, 2024

Cost counseling and stewardship need to be part of medical school curricula

In my third week as a medical intern, I learned a vital lesson about the realities of everyday medicine that textbooks and professors hadn’t taught

July 31, 2024

Cancer prevention and screening avert more deaths than treatment advances

Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment advances, according to

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.